Excellence in Professional Education Programmes

Sponsored by

← Back to results

Winner

ROSETTA-LUNG

by Ashfield MedComms (Inizio Medical) on behalf of AstraZeneca

Summary of work

Our digital platform transforms how healthcare professionals diagnose and treat lung cancer patients by revolutionising clinical alignment and decision-making. This innovative solution digitises a previously offline Danish program, creating a globally accessible training tool that improves consistency in patient care without imposing judgments. The platform presents 60 meticulously crafted fictitious patient cases, complete with comprehensive medical histories and CT scans. Healthcare professionals and multidisciplinary teams (MDTs) evaluate these cases through four structured question sets regarding diagnosis and treatment approaches. Their responses are then visualised within the spectrum of all MDTs’ decisions, revealing whether their approaches align with peers or represent outlier perspectives. What distinguishes this platform is its ability to:
  • Facilitate objective self-assessment without prescriptive feedback
  • Enable cross-regional or localised data comparison
  • Provide accessibility across any device, anywhere in the world
  • Adapt to various healthcare environments through localisation
Initially developed for specialists in lung cancer, the platform’s exceptional reception has prompted expansion into multiple oncology areas. This scalable digital solution addresses a critical healthcare challenge—patient staging and management variation—by creating a collaborative learning environment that respects clinical autonomy while promoting evidence-based alignment in patient care approaches.

Judges’ comments

‘ROSETTA-LUNG’ is an incredibly smart and practically-based solution for intra-regional variations in lung patient staging and treatment, which is a huge problem. The panel liked the MDT approach and thought it was clever to expand into international benchmarking. The judges recognised that the programme could save lives and were impressed by its potential application into other disease areas. A true example of where medcomms can improve patient outcomes.